Yes that matches my understanding. As to where the cells are actually being harvested and expanded, I have no idea.
Agreed that they are using Tigenix's adipose MSC's rather than Mesoblast's bone marrow sourced MSC's for this trial. I did read a paper the other day that compared immunomodulatory responses for MSC's derived from different tissue sources and as I recall both adipose and bone marrow derived cells worked well
MSB Price at posting:
$2.73 Sentiment: None Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)